RESULTS OF NEOADJUVANT CHEMOTHERAPY TREATMENT FOR HER2(+) BREAST CANCER USING A COMBINATION CHEMOTHERAPY REGIMEN WITH HER2 INHIBITORS AT NGHE AN ONCOLOGY HOSPITAL. YHCĐ 2026, 67 (Số CĐ12- Bệnh viện Ung bướu Nghệ An). https://doi.org/10.52163/yhc.v67iCD12.6146.